MGC Pharmaceutics Results – if you fancy more red flags vicar?
By Tom Winnifrith | Sunday 4 September 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
The numbers for the year to June 30 came out last Thursday. Forgive my delayed response but suffice to say that MGC (MXC) engaged in industrial scale turd polishing.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.